
228.68 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 92.26 Today|||52-Week Range 257.00 | +74.56% Year-to-Date |
The 14 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 260.50, with a high estimate of 315.00 and a low estimate of 160.00. The median estimate represents a +13.91% increase from the last price of 228.68.
The current consensus among 15 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.